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background. Despite a paucity of evidence, decolonization measures are prescribed for outpatients with recurrent Staphylococcus aureus skin and soft-tissue infection (SSTI).
objective. Compare the effectiveness of 4 regimens for eradicating S. aureus carriage.
design. Open-label, randomized controlled trial. Colonization status and recurrent SSTI were ascertained at 1 and 4 months. participants. Three hundred patients with community-onset SSTI and S. aureus colonization in the nares, axilla, or inguinal folds.
interventions. Participants were randomized to receive no therapeutic intervention (control subjects) or one of three 5-day regimens: 2% mupirocin ointment applied to the nares twice daily, intranasal mupirocin plus daily 4% chlorhexidine body washes, or intranasal mupirocin plus daily dilute bleach water baths.
results. Among 244 participants with 1-month colonization data, modified intention-to-treat analysis revealed S. aureus eradication in 38% of participants in the education only (control) group, 56% of those in the mupirocin group ( vs controls), 55% of those P p .03 in the mupirocin and chlorhexidine group ( ), and 63% off those in the mupirocin and bleach group ( ). Of 229 participants P p .05 P p .006 with 4-month colonization data, eradication rates were 48% in the control group, 56% in the mupirocin only group ( vs controls), P p .40 54% in the mupirocin and chlorhexidine group ( ), and 71% in the mupirocin and bleach group ( ). At 1 and 4 months, P p .51 P p .02 recurrent SSTIs were reported by 20% and 36% of participants, respectively.
conclusions. An inexpensive regimen of dilute bleach baths, intranasal mupirocin, and hygiene education effectively eradicated S. aureus over a 4-month period. High rates of recurrent SSTI suggest that factors other than endogenous colonization are important determinants of infection. Over the past decade, the incidence of staphylococcal skin and soft-tissue infections (SSTIs) has increased significantly.
1-3
Staphylococcus aureus colonization is a demonstrated risk factor for the development of SSTI. [4] [5] [6] Measures to eradicate S. aureus carriage, including intranasal mupirocin and bathing with chlorhexidine antiseptic, have been evaluated in the prevention of nosocomial infections. The effectiveness of these measures has varied across different studies and has been shown to wane over extended periods of time. [7] [8] [9] [10] [11] The recent increase in the incidence of SSTI in otherwise healthy individuals is largely attributable to a virulent, community-associated (CA) methicillin-resistant S. aureus (MRSA) clone designated USA300. 12 When this clone first emerged, it represented the majority of CA-MRSA isolates. More recently, similarly virulent strains of methicillinsusceptible S. aureus (MSSA) have also been shown by means of genotyping to originate from USA300. 2, 13 Genomic sequencing of the USA300 clone suggests that these strains possess novel gene content and altered regulation of virulence determinants, which may enhance colonization and survival. [14] [15] [16] Because of the distinct epidemiology, microbial characteristics, and pathogenesis of contemporary CA S. aureus strains, eradication strategies employed in healthcare settings may not be effective in preventing S. aureus transmission and infection in the community. The paucity of data available to guide the prevention of recurrent S. aureus SSTI in community settings, as highlighted by recently published Infectious Diseases Society of America MRSA clinical practice guidelines, has engendered a wide variety of treatment and decolonization practices. 17, 18 Traditional interventions, such as mupirocin or chlorhexidine, are often prescribed, 17, 19 and bathing in dilute bleach water has also been proposed, 3 but these measures have not been comprehensively evaluated with a randomized trial in the outpatient setting.
The primary objective of this study was to investigate the effectiveness of decolonization measures in eradicating S. aureus carriage from patients with SSTI in the community. The secondary objectives were to determine rates of recurrent SSTI among participants in the study arms and to evaluate the acceptability of and adherence to these eradication measures by study participants. We hypothesized that a decolonization regimen consisting of personal and household hygiene education and application of nasal mupirocin ointment with either chlorhexidine body washes or dilute bleach water baths would be twice as effective as hygiene education alone in eradicating S. aureus colonization.
methods

Study Design
The St. Louis Staphylococcus aureus Reduction Study (StL StaRS) was an open-label, randomized controlled trial at 2 hospitals that compared the effectiveness of 4 regimens to eradicate S. aureus carriage from patients with CA-SSTI and S. aureus colonization. This study was approved by the Washington University Human Research Protection Office.
Participants
Patients 6 months of age or older with acute, communityonset SSTI were screened from the Emergency Department (ED) and ambulatory wound center at St. Louis Children's Hospital (SLCH) and the Barnes-Jewish Hospital (BJH) ED. At the time of screening, verbal informed consent, demographic information, and colonization swab samples (BBL CultureSwab; Becton Dickinson) from the anterior nares, axilla, and inguinal folds were obtained. Patients were excluded if they had a postoperative wound infection, permanent indwelling catheter, or percutaneous medical device; were pregnant or receiving dialysis; or resided in a long-term care facility. Patients colonized with S. aureus (MRSA or MSSA) at one or more of the sampled sites were eligible for enrollment. (Table 1) . Written informed consent and assent, when applicable, were obtained at enrollment. Randomization was conducted by B.C.C. with an Internet-based, computer-generated randomization schedule using permutation blocks of 8. The designated intervention for each participant was sealed inside a numbered security envelope by S.A.F. and was opened at the enrollment visit by a research coordinator. Participants were randomized to receive 1 of 4 interventions:
Study Intervention and Randomization
Enrollment
1. Personal and household hygiene education only. This included instructions to discard lotions in jars and replace them with pump or pour bottles; refrain from sharing personal hygiene items (eg, hairbrushes, razors, or towels); wash (in hot water) bed linens at least once weekly and towels and washcloths after each use.
2. Education plus application of 2% mupirocin ointment to the bilateral anterior nares twice daily for 5 days.
3. Education and intranasal 2% mupirocin ointment in addition to daily body washes with 4% chlorhexidine solution (Hibiclens; Mölnlycke Health Care), used as a liquid soap, for 5 days.
4. Education and intranasal 2% mupirocin ointment in addition to daily 15-minute soaks in dilute bleach water (a quarter cup of 6% sodium hypochlorite [Clorox; Clorox Company] per tub of water) for 5 days.
Oral and written instructions and diagrams were provided to study participants. Intranasal application of mupirocin ointment using a sterile cotton applicator was demonstrated by the study staff. Participants or parents were then required to demonstrate the mupirocin application procedure to confirm their understanding. All study materials were supplied to the participants. For participants randomized to the bleach bath arm, a measuring cup marked at one-fourth cup was provided. Decolonization measures were completed by participants at home.
Data Collection at Baseline and Follow-Up
At enrollment, a questionnaire was administered to each participant to collect information regarding medical history, hygiene practices, household factors, employment, and other activities (factors listed in Table 1 ). Upon completion of the 5-day decolonization protocol, each participant was contacted by telephone to assess their adherence to the protocol, adverse reactions, and ease of performing each protocol step.
Participants were followed up longitudinally, with followup visits 1 and 4 months after randomization at the SLCH or BJH CRC. At each follow-up visit, participants had samples collected to detect S. aureus colonization in the anterior nares, axilla, and inguinal folds. A survey was administered to ascertain interval SSTI in the participant or a household member. Study participation concluded with a telephone call 6 months after enrollment to ascertain SSTI recurrence; all follow-up was completed by November 2009. Twelve participants were unable to return for follow-up visits because of (33) 28 (37) 23 (31) 20 (27) .56 Both MRSA and MSSA 8 (11) 8 (11) 8 (11) geographic location. For these participants, the survey was conducted by telephone, and swabs were delivered to the participant's home accompanied by a diagram and detailed instructions for obtaining and returning the culture swab samples (validated by our group and others 20, 21 ).
Study Outcomes
The primary outcome measure was eradication of S. aureus carriage 1 month after intervention. Eradication was defined as the absence of S. aureus carriage at the 3 sampled body sites. Secondary outcomes included S. aureus eradication at 4 months; recurrent SSTI at 1, 4, and 6 months; and acceptability of and adherence to the intervention methods.
Laboratory Methods
Swab samples were incubated overnight in tryptic soy broth with 6.5% NaCl (BBL; Becton Dickinson) at 35ЊC. A sample of broth was plated to trypticase soy agar with 5% sheep blood (BBL; Becton Dickinson) and incubated overnight. S. aureus isolates were identified and antibiotic susceptibility testing was performed according Clinical and Laboratory Standards Institute procedures as previously described. 22, 23 Laboratory personnel were blinded to randomization assignments. Follow-up swab samples collected by participants at home all yielded normal flora, which suggested that swab samples were indeed representative of the designated body sites.
Real-time polymerase chain reaction was performed for all recovered S. aureus isolates, using established primers, to detect the mupA gene encoding high-level mupirocin resistance.
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Statistical Analysis
Based on published data, 5 we anticipated 50% eradication of S. aureus carriage in the control group, who received only hygiene education. Based on this assumption, 57 participants per group were needed to detect a 50% relative reduction in S. aureus colonization at 1 month ( and study power a p 0.05 at 80%) when comparing each intervention group with the control group. To account for a possible 25% attrition, we enrolled 75 participants in each arm (300 total participants).
Demographic and baseline characteristics were evaluated with descriptive statistics. Outcomes were determined by modified intention-to-treat analysis, including participants who attended longitudinal visits. Statistical analyses were performed using SPSS for Windows, version 17.0 (SPSS) unless otherwise specified. Pearson's x 2 analyses and analysis of variance (or Kruskal-Wallis test where appropriate) were performed to compare characteristics among participants in the 4 study arms. Statistical significance values for relative risk (RR) and absolute risk reduction (ARR) for S. aureus eradication and recurrent SSTI between the control group and the intervention arms were determined by Pearson's x 2 .
Fisher's exact tests were performed using R (R Foundation) in cases of small cell sizes. Potential confounding baseline characteristics that differed significantly between arms (P ≤ ) were evaluated with binary logistic regression. All tests for .05 significance were 2-sided, and P values of ≤.05 were considered statistically significant. The RR was considered to be significant if the 95% confidence interval (CI) did not include 1.
results
Baseline Patient Characteristics
Of 782 patients with acute SSTI assessed for eligibility, 300 were enrolled in the trial. Participants were randomly allocated to 4 intervention groups of 75 participants each ( Figure  1) . Overall, 193 children (64%) and 107 adults (36%) were enrolled. The treatment groups were similarly distributed at baseline with the exception of sex, several comorbidities (asthma, eczema, allergies, and human immunodeficiency virus infection), and surgery within the past year (Table 1) . These factors did not influence the relationship between treatment group and outcomes (data not shown).
Primary and Secondary Outcomes
S. aureus eradication at 1 month. The 1-month colonization evaluation was completed by 244 participants. Modified intention-to-treat analysis revealed significantly greater S. aureus eradication with each of the 3 decolonization regimens, compared with the control group, which received only personal and household hygiene education. S. aureus eradication occurred in 38% of control subjects. Compared with control subjects, eradication was achieved for 56% of participants who were randomized to education plus mupirocin (P p vs control subjects); 55% of those who were randomized .03 to education, mupirocin, and chlorhexidine ( ); and P p .05 63% of those who were randomized to education, mupirocin, and bleach baths ( ; Table 2 ). P p .006 S. aureus eradication at 4 months. Colonization data were available for 229 participants at 4 months. S. aureus was eradicated from 48% of control subjects. Compared with control subjects, eradication was achieved in 56% of participants in the education plus mupirocin group ( ); 54% in the P p .40 education, mupirocin, and chlorhexidine group ( ); P p .51 and 71% in the education, mupirocin, and bleach baths group ( ; Table 2 ). P p .02
Body site-specific eradication. Colonization of the nares was significantly reduced at 1 and 4 months in all participants who received mupirocin, compared with control subjects. In addition, inguinal colonization was significantly lower at 1 month in participants who were randomized to bleach baths, compared with those who did not perform bleach baths (Table 3).
Rates of recurrent SSTI. Recurrent SSTI was reported by 20% of participants at 1 month, 36% at 4 months, and 49% at 6 months. There were significantly fewer reports of recurrent SSTI at 1 month by participants who received education, mupirocin, and chlorhexidine (11%) than by control subjects (26%;
; all other differences were not sig-P p .03 nificant; Table 4 ).
Protocol acceptability and adherence. No serious adverse events were reported. Of 283 participants who provided information, 39 reported adverse effects. The most common reactions included dry skin (in 21 [7%] of the participants), rash (9 [3%]), and rhinorrhea or nasal irritation (4 [1%] ). A greater number of reactions were experienced by participants who performed chlorhexidine body washes (20%) and bleach baths (25%) than by control subjects (6%; P p .01 and , respectively). Mupirocin, chlorhexidine P p .001 washes, and bleach baths were reportedly easy to perform for 84% (174 of 208), 82% (56 of 68), and 77% (51 of 66) of the participants, respectively. Of those with follow-up information, adherence to protocol assignment was reported by 72% of control subjects; 64% of participants in the education and mupirocin group; 70% of participants in the education, mupirocin, and chlorhexidine group; and 62% of participants in the education, mupirocin, and bleach baths group. In groups assigned to multiple interventions, adherence to hygiene measures was consistently lower than was adherence to topical treatments (Table 5) . discussion This is, to our knowledge, the first study to compare the effectiveness of multiple approaches for S. aureus eradication from multiple body sites in the community. Decolonization regimens employing intranasal mupirocin alone and in combination with chlorhexidine body washes or dilute bleach baths were effective in S. aureus eradication 1 month after the intervention, compared with personal and household hygiene education alone. Interestingly, only the regimen that combined hygiene education, intranasal mupirocin, and bleach baths achieved a statistically significant reduction in S. aureus colonization rates at 4 months.
The findings of this study are encouraging, because bleach is readily available and very affordable (approximately 40 cents per 5-day course of daily baths, compared with $10 per 8 fluid ounces of chlorhexidine). Bleach, or sodium hypochlorite, has S. aureus antimicrobial activity both in vivo and in vitro and has been used by dermatologists to treat eczema, presumably by suppressing S. aureus growth. [25] [26] [27] [28] Variable dilutions of bleach added to bathwater have been recommended. 3, 25, 27, 28 In this study, we asked participants to add one-quarter cup of bleach to a bathtub full of water. Although this presumably resulted in a range of dilutions among study participants, we wanted to make the intervention easy and practical. Considering typical bathtub sizes and volumes of water used, 27 we estimate that most bleach bath participants were exposed to sodium hypochlorite concentrations of 0.002%-0.009%. We believe that soaking in dilute bleach water provided the most exposure for all body parts, especially the inguinal folds, and that longer contact with bleach may have provided a greater antimicrobial effect. In fact, inguinal colonization was significantly reduced in patients in the bleach group, compared with those in the chlorhexidine group. In contrast, chlorhexidine was applied as liquid soap and rinsed off. Used in this manner, chlorhexidine likely provided little residual antimicrobial activity and may have had less contact with the inguinal area, which is a frequently colonized body site. 29 The use of chlorhexidine-impregnated cloths, in which chlorhexidine is not rinsed from the skin, may be more effective in S. aureus eradication. These cloths have been effective in preventing hospital-acquired infections in intensive care unit settings. 30, 31 Regardless of the setting (healthcare or community), agreement has not been reached regarding the optimal approach to S. aureus decolonization. Numerous decolonization studies, evaluating a variety of regimens, have been conducted in note. Data are proportion (%) of participants, unless otherwise indicated. The hygiene education only (control) group was used as the comparator group to determine relative risk (RR), absolute risk reduction (ARR), and P values. P value represents comparison between the intervention group and the control group. Participants were analyzed by the arm to which they were assigned. CI, confidence interval. healthcare settings to prevent nosocomial infections, with varying results. [7] [8] [9] [10] [11] 32, 33 For example, a meta-analysis of topical and systemic antimicrobials by Ammerlaan et al 32 concluded that short-term application of nasal mupirocin was highly effective for eradicating MRSA carriage and achieved a 90% success rate 1 week after treatment. However, other metaanalyses have focused on the nondurability of such beneficial effects and have concluded that there is insufficient evidence for the use of topical or systemic therapies for S. aureus eradication. 7, 33 As in decolonization studies conducted in healthcare settings, [7] [8] [9] we found that CA S. aureus eradication achieved at 1 month by the application of mupirocin alone or in combination with chlorhexidine washes was not sustained. Thus, an effective regimen for long-term S. aureus eradication remains unclear.
S. aureus colonization at sites other than the anterior nares, including the groin, axilla, and pharynx, has been identified by our group and others as reservoirs for a high burden of S. aureus carriage. 29, 34, 35 In accordance with this, the reported efficacy of intranasal mupirocin ointment is lower in studies that evaluate multiple body sites for colonization than in those that assess colonization of the nares alone. 32 Thus, an
approach that includes decolonization of extra-nasal sites of S. aureus carriage may be critical to prevent transmission and infection. Because of the relatively low cost of bleach, and because resistance to mupirocin can develop with widespread use, 36,37 a prolonged decolonization approach aimed at sustained eradication and consisting of dilute bleach baths without the use of intranasal mupirocin warrants further study. Orally administered antibiotics achieve short-term MRSA eradication rates approaching 60%, but antimicrobial resistance develops more commonly with regimens that include systemic antibiotics. 32 Despite the effectiveness of the studied interventions in reducing S. aureus colonization, participants in all study arms experienced a substantial rate of recurrent SSTI. In our cohort, 20% of participants reported recurrent SSTI within a month of study enrollment, which is consistent with other longitudinal studies. 38, 39 Similarly, in a study involving MRSAcolonized soldiers conducted by Ellis et al, 40 although application of mupirocin to the anterior nares successfully eradicated nasal carriage in the treated soldiers, it did not decrease infection rates in these soldiers or their peers. Because eradication of endogenous colonization alone does not eliminate note. Data are proportion (%) of participants, unless otherwise indicated. The hygiene education only (control) group was used as the comparator group to determine relative risk (RR), absolute risk reduction (ARR), and P values. P value represents comparison between the intervention group and the control group. Participants were analyzed by the arm to which they were assigned. CI, confidence interval; SSTI, skin or soft-tissue infection. note. Data are proportion (%) of participants. There was not a statistically significant difference in compliance with the assigned regimens between participants in the 4 randomization arms. Adherence for each protocol component was defined as completion of 3 hygiene steps (discarding lotions in jars, not sharing personal hygiene items, and washing bed linens and towels in hot water), mupirocin application twice daily for 5 days, chlorhexidine body washes daily for 5 days, and bleach baths daily for 5 days.
subsequent infection, an improved understanding of other determinants of CA S. aureus pathogenesis, including environmental factors and person-to-person transmission, is needed.
There are several limitations to this study. For logistical reasons, this randomized trial was conducted as an open trial, rather than as a blinded, placebo-controlled trial. Given the objective primary outcome (S. aureus eradication as determined by culture), we do not believe the lack of blinding introduced significant bias into the results. Although we did not directly monitor adherence to the measures, 67% of the participants reported adherence with assigned decolonization measures, and reported rates of compliance with therapeutic interventions (mupirocin, chlorhexidine, and bleach) were very high (190%). In addition, because of the pain and inconvenience of recurrent SSTI, we believe that many patients were motivated to complete the decolonization measures in an attempt to prevent future infection. Household members were not included in this trial and were not asked to perform the decolonization measures. CA S. aureus infections have been observed to cluster within households, 41 and study participants may have reacquired the organism from close household contacts. We are conducting a separate trial to compare the effectiveness of decolonization interventions directed at all household members with that of interventions directed at the index patient alone. Lastly, the incidence of recurrent SSTI was determined by patient report. We feel this was a valid measure given that each participant had experienced at least one prior SSTI (at the time of screening). In summary, a regimen of dilute bleach water baths, intranasal mupirocin, and personal and household hygiene education was effective for S. aureus eradication in the outpatient setting for individuals with CA-SSTI. Although our results may be generalizable to other diverse populations of children and adults colonized with contemporary S. aureus strains, additional studies are needed to evaluate prolonged or intermittent decolonization approaches. Larger multicenter trials evaluating the efficacy and cost-effectiveness of these measures in reducing the morbidity of recurrent SSTI in individuals and communities will be vital to improving the lives of patients who are affected by CA S. aureus.
